• Publications
  • Access to Maternal Health: Pharmaceutical Com...
Publication - published on 09 Apr 2015

Access to Maternal Health: Pharmaceutical Companies’ Contribution to MDG 5

This landscape study analyses data submitted by pharmaceutical companies on maternal health and access to contraceptives for the 2014 Access to Medicine Index, supplemented by additional desk research.

With the Sustainable Development Goals due to be launched this year, this report can be used as a baseline for monitoring whether and how individual research-based pharmaceutical companies are working to improve access to maternal and reproductive health. Measuring progress against such targets is key for maintaining momentum and focus.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.